Background {#Sec1}
==========

Vaginal examinations (VEs) are a routine part of labor progression assessment \[[@CR1]\]. They entail the subjective impression of cervical dilatation, effacement, consistency, and presenting part position \[[@CR2]\]. Although frequently overlooked, VEs are associated with maternal discomfort, and may negatively influence labor progress, by causing anxiety and diverting the focus of the laboring woman \[[@CR2], [@CR3]\]. Additionally, VEs following rupture of membranes have been demonstrated to increase the risk of chorioamnionitis \[[@CR4]--[@CR7]\]. Obstetricians are, therefore, routinely expected to weigh the need for VEs for the assessment of labor progression, against the risk of maternal discomfort and of infection with an increased number of examinations \[[@CR8], [@CR9]\].

Despite the World Health Organization's recommendation for a VE every 4 hours during labor \[[@CR10]\], a substantial number of women undergo VEs more frequently than recommended \[[@CR11]\]. In addition, there is currently no direct evidence regarding the optimal frequency or number of VEs to minimize infectious morbidity in the mother and newborn, and minimize maternal discomfort \[[@CR10]\]. One retrospective study found that the risk for maternal fever is not significantly increased by the number of VEs \[[@CR12]\]. However, it was limited by a relatively small sample size, and short postpartum follow-up (up to 6 hours postpartum).

Therefore, our aim was to study the association between the number of VEs performed during labor and maternal febrile morbidities, in a very large cohort of laboring women from a single tertiary center.

Methods {#Sec2}
=======

Data collection {#Sec3}
---------------

This was a retrospective cohort study. All women who delivered vaginally at a gestational age of 37 weeks or greater, in a single university affiliated hospital, between January 2008 and December 2017 were included. Cesarean deliveries, preterm deliveries (\< 37 weeks), known fetal malformations, intrauterine fetal death, and cases of missing data were excluded. We also excluded patients who were treated with prophylactic antibiotics during labor because of known Group B streptococcus carrier status, and/ or prolonged rupture of membranes (\> 18 h), and patients who had fever ≥38.0 °C prior to the first VE.

For each delivery, the number of VEs performed during labor, as well as the duration of labor (from admission to the delivery ward until the time of delivery) and the time from rupture of membranes until delivery were extracted from the computerized database. Data regarding the number of VEs performed prior to admission to the delivery ward was not extracted.

All women were admitted to the delivery ward in active labor, which was defined as a cervical dilatation ≥4 cm in the presence of regular uterine contractions, with or without rupture of the membranes. According to our departmental protocol, early amniotomy is performed in every labor (if membranes are intact), as part of an active management of labor.

The primary exposure was the number of VEs during labor as documented in the electronic medical record of each delivery. Our institutional protocol mandates full documentation of each examination. VEs were performed using sterile gloves and are primarily performed by obstetricians, residents, and midwives. A water based lubricant (Sion Biotext medical LTD. Hagoshrim, Israel) is used. Amniotomy is carried out by an obstetrician, with the hook handed to her/ him by the midwife, so the hand is not removed throughout the examination and amniotomy. During labor, vital signs (including body temperature- measured orally) were measured every 2 hours, or in case of a clinical suspicion of maternal fever (maternal or fetal tachycardia, flushing, etc.). Patients are routinely discharged from the maternity ward 2 days following vaginal deliveries.

Data regarding background and obstetric characteristics, mode of delivery, delivery complications, and postpartum complications (until the patients were discharged from the hospital) were reviewed as well. The outcomes evaluated were the following delivery complications: intrapartum febrile morbidity (intrapartum fever ≥38.0 °C and/or culture-proven chorioamnionitis), postpartum febrile morbidity (postpartum fever ≥38.0 °C from the 2nd to the 10th day following delivery, and/or culture-proven endometritis), and peripartum febrile morbidity (defined as intrapartum or postpartum). Postpartum febrile morbidities were analyzed after the exclusion of patients with intrapartum febrile morbidities.

Statistics {#Sec4}
----------

Data were analyzed using SPSS statistical analysis software v23.0 (IBM Inc., USA). Continuous variables were compared by the ANOVA test, and categorical variables were compared by chi-square test. All tests were two sided, and a *p*-value \< 0.05 was considered statistically significant.

In order to study the association between the number of VEs and delivery complications, the cohort was divided according to the number of VEs performed during labor as follows: up to 4 VEs, 5--6 VEs, 7--8 VEs, and 9 or more VEs.

In order to identify independent variables associated with febrile morbidity complications, we performed a multivariate logistic regression analysis. Each complication (as defined above) served as the dependent variable and the following variables served as independent variables: maternal age, diabetes mellitus, maternal body mass index (BMI), gestational age, type of delivery (normal vaginal or instrumental), duration of labor and the time form rupture of membranes to delivery.

Results {#Sec5}
=======

During the study period, a total of 37,827 women delivered at our medical center. Of them, a total of 22,183 women were included in the study (Fig. [1](#Fig1){ref-type="fig"}). The cohort was divided according to study groups, as detailed above: up to 4 VEs (*n* = 9716), 5--6 VEs (*n* = 4624), 7--8 VEs (2999), and 9 or more VEs (*n* = 4844). Maternal demographics of the entire cohort are presented in Table [1](#Tab1){ref-type="table"}. The groups differed in duration of labor (up to 4 VEs: 184 ± 122, 5--6 VEs: 349 ± 163, 7--8 VEs: 490 ± 204, 9 or more VEs: 682 ± 308 min, *p* \< 0.001) and the time form rupture of membranes to delivery (up to 4 VEs: 180 ± 179, 5--6 VEs: 250 ± 220, 7--8 VEs: 321 ± 231, 9 or more VEs: 422 ± 269 min, p \< 0.001). Fig. 1Cohort analysis flowchartTable 1Maternal demographics of the study cohortDemographic dataUp to 4 VEs (*n* = 9716)5--6 VEs (*n* = 4624)7--8 VEs (*n* = 2999)9 or more VEs (n = 4844)*p*-valueMaternal age (years)30.1 (5.2)29.6 (5.5)29.2 (5.4)28.7 (5.4)**\< 0.001**BMI (kg/m^2^)23.1 (3.6)23.3 (3.9)23.3 (3.9)23.5 (4.1)**\< 0.001**Obesity508 (5.5)251 (5.4)180 (6.0)369 (7.6)**\< 0.001**Gestational age (weeks)39.6 (1.1)39.6 (1.1)39.6 (1.1)39.6 (1.2)**\< 0.001**Nulliparity2306 (23.7)1727 (31.6)1563 (52.1)3521 (72.6)**\< 0.001**Birthweight (grams)3271 (407)3287 (418)3313 (422)3333 (599)**\< 0.001**Small for gestational age389 (4.1)173 (3.7)100 (3.3)165 (3.4)0.311Macrosomia465 (4.9)205 (4.4)169 (5.6)292 (6.0)**\< 0.001**Smoking1046 (10.8)543 (11.7)386 (12.9)1052 (21.7)**\< 0.001**TOLAC536 (5.5)227 (4.9)179 (5.9)284 (5.9)**\< 0.001**Induction of labor2733 (28.1)1448 (31.3)999 (33.3)2117 (43.7)**\< 0.001**Epidural6993 (72.0)3813 (82.5)2603 (87.8)4354 (89.9)**\< 0.001**Spontaneous ROM1395 (14.4)560 (12.1)348 (11.6)503 (10.4)**\< 0.001**Amniotomy8321 (85.6)4064 (87.9)2651 (88.4)4341 (89.6)**\< 0.001**Normal vaginal delivery9377 (96.1)4320 (93.4)2729 (91.0)4105 (84.7)**\< 0.001**Instrumental delivery211 (3.9)304 (6.6)270 (9.0)739 (15.3)**\< 0.001**Diabetes mellitus625 (6.4)323 (7.0)237 (7.9)406 (8.4)**\< 0.001**Gestational hypertensive disorders575 (5.9)250 (5.4)185 (6.2)314 (6.5) \<0.001Chronic hypertension45 (0.4)16 (0.3)23 (0.8)32 (0.4)**0.012**Labor duration (min)184 (122)349 (163)490 (204)682 (308)**\< 0.001**ROM to delivery duration180 (179)250 (220)321 (231)422 (269)**\< 0.001**Data are presented as mean (SD) or n (%)*BMI* body mass index, *TOLAC* Trial of labor after cesarean delivery ROM rupture of membrane, Gestational hypertensive disorders include eclampsia, preeclampsia; and gestational hypertensionValues in bold are statistically significant

A univariate analysis of febrile morbidity complications according to the number of VEs during labor is presented in Table [2](#Tab2){ref-type="table"}. The rate of febrile complications increased with an increase in the number of VEs performed during delivery: intrapartum fever (up to 4 VEs: 0.23%, 5--6 VEs: 0.77%, 7--8 VEs: 2.16%, 9 or more VEs: 4.54%, *p* \< 0.001), chorioamnionitis (up to 4 VEs: 0.87%, 5--6: 1.55%, 7--8 VEs: 2.63%, 9 or more VEs: 7.03%, *p* \< 0.001), postpartum fever (up to 4 VEs: 0.57%, 5--6 VEs: 1.23%, 7--8 VEs: 2.23%, 9 or more VEs: 2.86%, *p* \< 0.001), and endometritis (up to 4 VEs: 0.07%, 5--6 VEs: 0.11%, 7--8 VEs: 0.17%, 9 or more VEs: 0.29%, *p* \< 0.001). The rates of intrapartum febrile morbidity (up to 4 VEs: 1.11%, 5--6 VEs: 2.32%, 7--8 VEs: 4.8%, 9 or more VEs: 11.58%, *p* \< 0.001), postpartum febrile morbidity (up to 4 VEs: 0.65%, 5--6 VEs: 1.37%, 7--8 VEs: 2.45%, 9 or more VEs: 3.18%, p \< 0.001), and peripartum febrile morbidity (up to 4 VEs: 1.76%, 5--6 VEs: 3.67%, 7--8 VEs: 7.2%, 9 or more VEs: 14.73%, p \< 0.001) were also differed between the groups. Table 2Univariate analysis of febrile morbidity complications according to the number of vaginal examinations during laborComplicationsUp to 4 VEs (*n* = 9716)5--6 VEs (*n* = 4624)7--8 VEs (*n* = 2999)9 or more VEs (*n* = 4844)*p*-valueIntrapartum fever23 (0.23)36 (0.77)65 (2.16)220 (4.54)**\< 0.001**Chorioamnionitis85 (0.87)72 (1.55)79 (2.63)341 (7.03)**\< 0.001**Intrapartum febrile morbidity108 (1.11)108 (2.32)144 (4.8)561 (11.58)**\< 0.001**Postpartum fever56 (0.57)57 (1.23)67 (2.23)139 (2.86)**\< 0.001**Endometritis7 (0.07)5 (0.11)5 (0.17)14 (0.29)**\< 0.001**Postpartum febrile morbidity63 (0.65)62 (1.37)72 (2.45)153 (3.18)**\< 0.001**Any febrile morbidity171 (1.76)170 (3.67)216 (7.2)714 (14.73)**\< 0.001**Data are presented as n (%)Values in bold are statistically significant

Logistic regression models in which febrile morbidity complications served as the dependent variables are presented in Table [3](#Tab3){ref-type="table"}. We found that performing 5 or more VEs during labor was independently associated with intrapartum febrile morbidity (5--6 VEs: aOR = 1.83, 95% CI (1.29--2.61), 7--8: aOR = 2.65 95% CI (1.87--3.76), 9 or more VEs: aOR = 3.47 95% CI (2.44--4.92)), postpartum febrile morbidity (5--6 VEs: aOR = 1.29, 95% CI (1.09--1.86), 7--8 VEs: aOR = 1.94 95% CI (1.33--2.83), 9 or more VEs: aOR = 1.91 95% CI (1.28--2.82)), and peripartum morbidity (5--6 VEs: aOR = 1.48, 95% CI (1.15--1.91), 7--8 VEs: aOR = 2.15 95% CI (1.66--2.78), 9 or more VEs: aOR = 2.57 95% CI (1.97--3.34)). Table 3Odd ratios for febrile morbidity complications in a logistic regression modelNumber of VEsIntrapartum febrile morbidityPostpartum febrile morbidityPeripartum febrile morbidityUnadjusted ORAdjusted ORUnadjusted ORAdjusted ORUnadjusted ORAdjusted OR**Up to 4**111111**5--62.85 (2.03--4.02)1.83 (1.29--2.61)1.74 (1.22--2.48)1.29 (1.09--1.86)2.23 (1.74--2.86)1.48 (1.15--1.91)7--85.81 (4.19--8.03)2.65 (1.87--3.76)3.19 (2.27--4.48)1.94 (1.33--2.83)4.37 (3.45--5.54)2.15 (1.66--2.78)9 or more12.81 (9.67--16.95)3.47 (2.44--4.92)4.09 (3.06--5.48)1.91 (1.28--2.82)8.19 (6.71--10.01)2.57 (1.97--3.34)**"Up to 4 VEs" serves a reference. Data are represented as OR (95%CI)OR was adjusted for maternal age, diabetes mellitus, BMI, gestational age, type of delivery, duration of labor, and the time form rupture of membranes to deliveryValues in bold are statistically significant

When VEs was analyzed as a continuous variable, each VE above 4 raised the risk for intrapartum febrile morbidity by 2%, for postpartum febrile morbidity by 1%, and for peripartum febrile morbidity by 1%.

Discussion {#Sec6}
==========

Main findings {#Sec7}
-------------

In the current study, we have demonstrated that the performance of five or more VEs during labor was associated with an increased risk for all febrile morbidities (Table [3](#Tab3){ref-type="table"}). We also found that for intrapartum and peripartum febrile morbidity, the risk is greater as the number of VEs increases.

Strengths and limitations {#Sec8}
-------------------------

The current study is notable for several points of strength. First, to the best of the authors' knowledge and based on literature search, it is the largest cohort to date (almost 24,000 patients) to examine the association between febrile morbidity and VEs during delivery. Second, by reviewing a minimal 48-h postpartum course, we were able to include postpartum febrile morbidity as an outcome. Third, by performing multivariant analysis, we addressed possible confounders, such as the duration of labor, which allows us to study the independent association between the number of VEs and delivery complications.

Our study is not without limitation, as it is mainly limited by its retrospective design, which might pose a potential bias: it is reasonable to assume that women who became febrile in labor may have been monitored more closely and as a result underwent more VEs. That may potentially be interpreted as a cause and effect, even though the predictor and outcome are actually reversed in that hypothetical scenario. Although it may have affected the results of intrapartum febrile morbidity, postpartum febrile morbidities were analyzed after the exclusion of intrapartum febrile patients, hence were not affected.

Another limitation is that we did not analyze the effect of the time interval between VEs to delivery: it is reasonable to assume that a VE performed far from delivery carries a higher risk for ascending infection than a VE performed close to delivery. However, we managed to partially overcome this confounder by including labor duration in the multivariant analysis.

Third, we are aware of the possibility of VEs which were performed but not electronically recorded, thus were not included in the statistical analysis. Yet, since according to our departmental protocol it is mandatory to report every examination (including cases of re-examination by a second medical crew member for validation of the former), it's safe to assume that missing data are rare.

Interpretation {#Sec9}
--------------

Multiple VEs have been proposed as a risk factor for both chorioamnionitis and postpartum endometritis, as they increase the exposure of the uterine cavity to the vaginal flora \[[@CR6], [@CR7], [@CR13]\]. Soper et al. \[[@CR8]\] prospectively evaluated 5399 patients for risk factors for the development of intraamniotic infection. In addition to prolonged rupture of membrane and the use of internal monitor, the authors reported that performing more than four VEs during labor at term independently triples the risk for intraamniotic infection. Seaward et al. \[[@CR9]\] retrospectively determined predictors for the development of chorioamnionitis and postpartum fever in 5028 patients with premature rupture of membranes at term. The authors found that an increased number of VEs is a risk factor for chorioamnionitis. On the other hand, Cahill et al. \[[@CR12]\], who retrospectively estimated the association between number of cervical examinations and risk of maternal fever during term labor, failed to demonstrate this correlation, and reported that the number of VEs during labor was not associated with an increased risk of maternal infection (*n* = 2395). Notably, the latter consisted of a relatively small sample size, and included only intrapartum and early postpartum (up to 6 hours after delivery) febrile morbidities. Therefore, it is safe to assume that our results, which are based on a large cohort and a longer postpartum follow-up, validate the potential risk of multiple VEs for febrile morbidity, as was formerly discussed \[[@CR8], [@CR9]\].

The study groups differed significantly in potential confounders: prolonged rupture of membranes, obesity, and diabetes mellitus are known risk factors for febrile morbidity; Epidural anesthesia is associated with increased body temperature; Patients who undergo induction of labor are often being examined before reaching the stage of active labor. Induction of labor is therefore associated with more VEs than spontaneous labor. Therefore, the results of the current study should be interpreted with caution. In order to minimize the risk for bias, and to explore the independent association between the number of VEs and the risk for febrile morbidity, a regression analysis model was performed, in which carefully selected potential confounders were adjusted for.

Conclusions {#Sec10}
===========

The number of VEs performed during labor directly correlates with febrile morbidity. Although, in clinical practice it seems difficult to isolate the number of VEs as a stand- alone variable, after careful statistical analysis, it was found that performing 5 VEs or more independently increased the risk for febrile morbidity. For intrapartum and peripartum febrile morbidity the risk was higher with an increase in the number of VEs.

This data should be taken into account when considering the benefits and necessity of multiple VEs, and should be considered by obstetricians while deciding regarding the number of VEs to perform during labor. This data can also assist organizations and institutions in the establishment of local protocols, to guide caregivers regarding the number and frequency of VEs to be performed in labor.

VE

:   Vaginal examination

BMI

:   Maternal body mass index
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